DREAMER: Intensified neoadjuvant-adjuvant management of resectable esophageal adenocarcinoma — multicentre, phase II, single-arm study
Sponsor: Centro Di Riferimento Oncologico Di Aviano
Phase: 2
Disease: Resectable esophageal adenocarcinoma, Resectable Siewert type I-II gastroesophageal junction adenocarcinoma
EU trial number: 2026-526333-25-00
Population: Adults ≥18 years with previously untreated histologically confirmed, locally advanced, resectable esophageal or Siewert I-II gastroesophageal junction adenocarcinoma (cT1N1-2 or cT2-3N0-2, M0), ECOG 0–1 and adequate organ function, appropriate for surgery.
Register Investigator Interest
Interested in offering this trial to suitable patients?